Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Clinical Endocrinology
|
February 24, 2001
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway
A G Myhre, M Halonen, P Eskelin, et al.
Clinical and Experimental Immunology
|
June 9, 2000
Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies
E S Husebye, A S Boe, F Rorsman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I
E S Husebye, G Gebre-Medhin, T Tuomi, et al.
Scandinavian Journal of Immunology
|
May 4, 2011
Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins
B E V Oftedal, O Kämpe, A Meager, et al.
Genes and Immunity
|
January 18, 2008
AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I
A S Bøe Wolff, B Oftedal, S Johansson, et al.
American Journal of Human Genetics
|
June 19, 2001
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
D Astuti, F Latif, A Dallol, et al.
Clinical Endocrinology
|
April 10, 1999
A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
E H Kemp, R A Ajjan, E S Husebye, et al.
Clinical Endocrinology
|
March 24, 1998
A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes
F Sköldberg, L Grimelius, E R Woodward, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2009
Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation
K Løvås, T H Røst, J Skorve, et al.
Scandinavian Journal of Immunology
|
January 5, 2011
TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus
C J A Smith, M Oscarson, L Rönnblom, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Clinical Endocrinology
|
February 24, 2001
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway
A G Myhre, M Halonen, P Eskelin, et al.
Clinical and Experimental Immunology
|
June 9, 2000
Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies
E S Husebye, A S Boe, F Rorsman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I
E S Husebye, G Gebre-Medhin, T Tuomi, et al.
Scandinavian Journal of Immunology
|
May 4, 2011
Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins
B E V Oftedal, O Kämpe, A Meager, et al.
Genes and Immunity
|
January 18, 2008
AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I
A S Bøe Wolff, B Oftedal, S Johansson, et al.
American Journal of Human Genetics
|
June 19, 2001
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
D Astuti, F Latif, A Dallol, et al.
Clinical Endocrinology
|
April 10, 1999
A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
E H Kemp, R A Ajjan, E S Husebye, et al.
Clinical Endocrinology
|
March 24, 1998
A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes
F Sköldberg, L Grimelius, E R Woodward, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2009
Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation
K Løvås, T H Røst, J Skorve, et al.
Scandinavian Journal of Immunology
|
January 5, 2011
TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus
C J A Smith, M Oscarson, L Rönnblom, et al.
Page
of 5